These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

853 related items for PubMed ID: 2548711

  • 1. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
    Elder DE, Rodeck U, Thurin J, Cardillo F, Clark WH, Stewart R, Herlyn M.
    Cancer Res; 1989 Sep 15; 49(18):5091-6. PubMed ID: 2548711
    [Abstract] [Full Text] [Related]

  • 2. Characteristics of cultured human melanocytes isolated from different stages of tumor progression.
    Herlyn M, Thurin J, Balaban G, Bennicelli JL, Herlyn D, Elder DE, Bondi E, Guerry D, Nowell P, Clark WH.
    Cancer Res; 1985 Nov 15; 45(11 Pt 2):5670-6. PubMed ID: 4053039
    [Abstract] [Full Text] [Related]

  • 3. The differential reactivity of cells of the melanocytic lineage with four monoclonal antibodies against IFN-gamma inducible molecules.
    Vacca A, Frassanito A, Rimoldi D, Dammacco F, Carrel S.
    Anticancer Res; 1992 Nov 15; 12(1):1-9. PubMed ID: 1348919
    [Abstract] [Full Text] [Related]

  • 4. Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma.
    Guerry D, Alexander MA, Elder DE, Herlyn MF.
    J Immunol; 1987 Jul 01; 139(1):305-12. PubMed ID: 3108402
    [Abstract] [Full Text] [Related]

  • 5. Tumor progression in the human melanocytic system.
    Kath R, Rodeck U, Menssen HD, Mancianti ML, Linnenbach AJ, Elder DE, Herlyn M.
    Anticancer Res; 1989 Jul 01; 9(4):865-72. PubMed ID: 2554787
    [Abstract] [Full Text] [Related]

  • 6. The initial steps of tumor progression in melanocytic lineage: a histochemical approach.
    Wollina U, Kilian U, Henkel U, Schaarschmidt H, Knopf B.
    Anticancer Res; 1991 Jul 01; 11(4):1405-14. PubMed ID: 1746897
    [Abstract] [Full Text] [Related]

  • 7. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
    Real FX, Houghton AN, Albino AP, Cordon-Cardo C, Melamed MR, Oettgen HF, Old LJ.
    Cancer Res; 1985 Sep 01; 45(9):4401-11. PubMed ID: 4028024
    [Abstract] [Full Text] [Related]

  • 8. Surface antigenic profile of uveal melanoma lesions analysed with a panel of monoclonal antibodies directed against cutaneous melanoma.
    Carrel S, Schreyer M, Gross N, Zografos L.
    Anticancer Res; 1990 Sep 01; 10(1):81-9. PubMed ID: 1692197
    [Abstract] [Full Text] [Related]

  • 9. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
    Kageshita T, Ishihara T, Campoli M, Ferrone S.
    Tissue Antigens; 2005 May 01; 65(5):419-28. PubMed ID: 15853896
    [Abstract] [Full Text] [Related]

  • 10. Recombinant gamma-interferon induces changes in expression and shedding of antigens associated with normal human melanocytes, nevus cells, and primary and metastatic melanoma cells.
    Herlyn M, Guerry D, Koprowski H.
    J Immunol; 1985 Jun 01; 134(6):4226-30. PubMed ID: 2985706
    [Abstract] [Full Text] [Related]

  • 11. Immunohistological characterisation of tumour infiltrating lymphocytes in melanocytic skin lesions.
    Hussein MR, Elsers DA, Fadel SA, Omar AE.
    J Clin Pathol; 2006 Mar 01; 59(3):316-24. PubMed ID: 16505286
    [Abstract] [Full Text] [Related]

  • 12. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H, Baril P, Tabone E, Bérard F, Sanhadji K, Balme B, Wolf F, Perrot H, Thomas L.
    Cancer Res; 2000 Oct 15; 60(20):5848-56. PubMed ID: 11059782
    [Abstract] [Full Text] [Related]

  • 13. Tumor progression in melanoma: the biology of epidermal melanocytes in vitro.
    Mancianti ML, Herlyn M.
    Carcinog Compr Surv; 1989 Oct 15; 11():369-86. PubMed ID: 2646021
    [Abstract] [Full Text] [Related]

  • 14. Biology of tumor progression in human melanocytes.
    Herlyn M, Clark WH, Rodeck U, Mancianti ML, Jambrosic J, Koprowski H.
    Lab Invest; 1987 May 15; 56(5):461-74. PubMed ID: 3553733
    [Abstract] [Full Text] [Related]

  • 15. Differential expression of melanoma associated antigens in acral lentiginous melanoma and in nodular melanoma lesions.
    Kageshita T, Nakamura T, Yamada M, Kuriya N, Arao T, Ferrone S.
    Cancer Res; 1991 Mar 15; 51(6):1726-32. PubMed ID: 1671829
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical analysis of malignant melanomas and nevocellular nevi with monoclonal antibodies to distinct monomorphic determinants of HLA antigens.
    Ruiter DJ, Bergman W, Welvaart K, Scheffer E, van Vloten WA, Russo C, Ferrone S.
    Cancer Res; 1984 Sep 15; 44(9):3930-5. PubMed ID: 6204749
    [Abstract] [Full Text] [Related]

  • 17. Antigenic profiles of individual-matched pairs of primary and melanoma metastases.
    Meije CB, Swart GW, Lepoole C, Das PK, Van den Oord JJ.
    Hum Pathol; 2009 Oct 15; 40(10):1399-407. PubMed ID: 19386352
    [Abstract] [Full Text] [Related]

  • 18. Adhesion molecule profile and malignancy of melanocytic lesions.
    Moretti S, Martini L, Berti E, Pinzi C, Giannotti B.
    Melanoma Res; 1993 Aug 15; 3(4):235-9. PubMed ID: 8219755
    [Abstract] [Full Text] [Related]

  • 19. Association between sialyl Lewis(a) expression and tumor progression in melanoma.
    Kageshita T, Hirai S, Kimura T, Hanai N, Ohta S, Ono T.
    Cancer Res; 1995 Apr 15; 55(8):1748-51. PubMed ID: 7712483
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic assessment of two novel proliferation-specific antigens in benign and malignant melanocytic lesions.
    Rudolph P, Lappe T, Schubert C, Schmidt D, Parwaresch RM, Christophers E.
    Am J Pathol; 1995 Dec 15; 147(6):1615-25. PubMed ID: 7495287
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.